Related Experiment Video
Updated: Mar 18, 2026
High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities
Published on: November 15, 2013
[Not Available]
Amenan Geneviève N'Guessan-Irié1, Jean-Claude Yavo2, Antoine Serge Guillaume Amari3
1Direction de la Pharmacie et du Médicament, Abidjan, Côte d'Ivoire; Laboratoire de Pharmacologie, de Pharmacie Clinique, de Thérapeutique et de Physiologie, UFR des Sciences Pharmaceutiques et Biologiques Université de Cocody Abidjan, Côte d'Ivoire.
Study'S Aim:
This study aims a more efficient follow-up of the safety of medicines with human usage on the Ivory Coast territory.
Method:
The structure responsible for pharmacovigilance in Ivory Coast i.e. DPM listed the medicinal alerts from 2001 till 2010.
Results:
It emerges 237 medicinal alerts among which 145 stops of marketing, 55 withdrawals of lots, 33 information notes and 4 levying of suspension of medicines. These alerts result mainly from pharmaceutical companies (49%) and the French Drug Agency or ANSM (ex-Afssaps) (43%). They mainly concern drugs of infectious target (22%) and pneumology (18%) and their motivations are so much industrial with mainly commercial reasons (27%) as of pharmacovigilance dominated by unfavorable profit/risk connections.
Conclusion:
These results constitute an important database for the survey of the medicines market in Ivory Coast and an additional motivation to accelerate the implementation of a real national center of pharmacovigilance.
